Sign In
Buy ACON
$2.69
-0.154 (-5.41%)
At Close: Jul 13, 2026
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
06:00am, Wednesday, 23'rd Apr 2025
BROOMFIELD, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and pr
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
06:00am, Monday, 21'st Apr 2025
Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgic
